Confluence Investment Management LLC Abbott Laboratories Transaction History

Confluence Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 16, 2019	SELL	$66.22 - $80.06 $352,687 - $426,399	-5,326 Closed	0 $0
Q4 2018 Jan 04, 2019	SELL	$65.56 - $74.27 $247,554 - $280,443	-3,776 Reduced 41.49%	5,326 $385,000
Q3 2018 Oct 25, 2018	SELL	$60.81 - $73.36 $343,211 - $414,043	-5,644 Reduced 38.27%	9,102 $668,000
Q2 2018 Jul 12, 2018	SELL	$57.57 - $63.54 $40,241 - $44,414	-699 Reduced 4.53%	14,746 $899,000
Q1 2018 Apr 04, 2018	BUY	$56.27 - $63.62 $568,720 - $643,007	10,107 Added 189.34%	15,445 $925,000
Q4 2017 Jan 08, 2018	BUY	$53.68 - $57.47 $40,098 - $42,930	747 Added 16.27%	5,338 $305,000
Q3 2017 Oct 13, 2017	BUY	$48.06 - $53.64 $220,643 - $246,261	4,591	4,591 $245,000

3,187

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Confluence Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Confluence Investment Management LLC with notifications on news.